In parallel, mouse IL-2 muteins with enhanced Treg selectivity and in vivo half-life, expanded highly suppressive Tregs in tissues (298) and controlled autoimmunity in the mouse NOD T1D model (299). This evidence concerns the gene IL2 and type 1 diabetes mellitus.